Search for new top exec begins as ACC develops strategic plan for 2019-2023 Jacobovitz Shal Jacobovitz is stepping down as CEO of the American College of Cardiology Feb. 2 to return to the biopharmaceutical industry. He will become CEO of CiVi Biopharma, a privately held company founded in 2016. ACC plans a nationwide search to find a successor. Executive Vice President and COO Cathy Gates will lead the organization as interim CEO. The medical society has more than 52,000 members and reported revenue of $117 million in 2015. The ACC was looking for innovation when it hired Jacobovitz in April 2013, and for someone who could seize opportunities in a rapidly changing… Read More